DoseCraft · Peptide Dosing AtlasFREE · NO SIGNUP
The Peptide Dosing Atlas
Practitioner-grade dosing for 93 research peptides across 11 categories. Ranges synthesized from named clinicians, peer-reviewed trials, and real-world protocols — not generic textbook figures.
On iPhone: tap Share → Print, then pinch out to save as PDF.
Full library → search, filter, deep dossiersCompounds93
FDA-cleared26
Categories11
Evidence tierTier 1· FDA-approved / strong clinical evidenceTier 2· Robust research / clinical trialsTier 3· Emerging research / animal studiesTier 4· Early-stage / anecdotal
Healing & Tissue Repair
6 compoundsBPC-157
Body Protection Compound-157
Dose500–1000 mcg/day
RouteSubQ
Frequency1–2x daily (AM/PM)
Cycle6–8 weeks typical cycle
Half-life4–6 hours
BPC-157 (Oral) — INEFFECTIVE
BPC-157 Capsules
DoseN/A — oral route is ineffective
RouteOral
FrequencyUse SubQ injection: 500mcg-1mg, 1-2x daily
CycleN/A
Half-lifeN/A — destroyed before absorption
Pentosan Polysulfate
PPS
Dose2–3 mg/kg SC twice weekly
RouteSubQ
FrequencyTwice weekly for loading, then weekly maintenance
Cycle6–12 week cycles
Half-life20–24 hours
Thymosin Beta 4
TB-4
Dose750 mcg – 2 mg/day
RouteSubQ
FrequencyOnce daily or split AM/PM
Cycle6–8 week cycles
Half-life~2 hours (rapidly processed to active fragments)
GHK
Glycyl-L-Histidyl-L-Lysine
Dose100–200 mcg/day SC
RouteSubQ
FrequencyOnce daily
Cycle8–12 week cycles
Half-life~30 minutes (rapid tissue uptake)
BPC-157 Arginate — ORAL STILL INEFFECTIVE
BPC-157 Arginine Salt
Dose250–500 mcg/day subcutaneous
RouteSubQ
Frequency1–2x daily SubQ injection
Cycle4–12 weeks
Half-life~4 hours
Recovery & Anti-Inflammatory
1 compoundTB-500
Thymosin Beta-4
Dose5 mg every 5 days (loading), 2.5 mg every 5 days (maintenance)
RouteSubQ
FrequencyEvery 5 days (loading and maintenance)
Cycle4 weeks loading + 4 weeks maintenance
Half-life~24 hours
Growth Hormone Axis
21 compoundsCJC-1295 / Ipamorelin
CJC/Ipa
DoseCJC: 100–300 mcg + Ipa: 100–300 mcg per dose
RouteSubQ
Frequency1–2x daily (bedtime essential, optional morning)
Cycle12 weeks on, 4 weeks off
Half-lifeCJC-1295: 6–8 days (DAC) | Ipamorelin: 2 hours
GHRP-6
Growth Hormone Releasing Peptide-6
Dose100–200 mcg per dose
RouteSubQ
Frequency3x daily
Cycle8–12 weeks, cycle off 4 weeks
Half-life~15–60 minutes
Tesamorelin
Egrifta
Dose1–2 mg daily
RouteSubQ
FrequencyOnce daily at bedtime
Cycle3–6 month cycles
Half-life26 minutes
Sermorelin
Geref
Dose200–500 mcg nightly
RouteSubQ
FrequencyOnce daily at bedtime
Cycle3–6 months, cycle off 1 month
Half-life10–20 minutes
MK-677 (Ibutamoren)
Ibutamoren
Dose10–25 mg nightly
RouteOral
FrequencyOnce daily at bedtime
Cycle8 weeks on, 4 weeks off
Half-life24 hours
CJC-1295 (No DAC)
Mod GRF 1-29
Dose100–200 mcg per dose (with equal Ipamorelin)
RouteSubQ
Frequency2–3x daily (AM, pre-workout, bedtime)
Cycle12 weeks on, 4 weeks off
Half-life~30 minutes
CJC-1295 (no DAC) + GHRP-2
Mod GRF 1-29 + GHRP-2
Dose100 mcg CJC + 100–300 mcg GHRP-2, 2–3x/day
RouteSubQ
Frequency2–3 times daily: AM fasted, post-workout, and pre-bed
Cycle12–16 week cycles with 4-week breaks
Half-lifeCJC-1295 no DAC: ~30 min; GHRP-2: ~15–25 min
GHRP-2
Growth Hormone Releasing Peptide 2
Dose100–200 mcg per injection (stay ≤200 mcg to limit cortisol)
RouteSubQ
Frequency2–3 times daily, always fasted
Cycle12–16 week cycles
Half-life~15–25 minutes
Hexarelin
Examorelin
Dose100–200 mcg SC, 1–2x/day
RouteSubQ
Frequency1–2 times daily, strict 2-week cycles
Cycle2 weeks on / 2 weeks off, repeat as needed
Half-life~70 minutes
Anamorelin
ONO-7643
Dose50–100 mg/day oral
RouteOral
FrequencyOnce daily, fasted
Cycle12–24 weeks minimum for body composition effects
Half-life~7 hours
CJC-1295 with DAC
CJC-1295 DAC
Dose1–2 mg weekly
RouteSubQ
Frequency1–2x per week
Cycle8–12 week cycles
Half-life6–8 days
HGH Fragment 176-191
Fragment 176-191
Dose250–500 mcg per day, split into 2 doses
RouteSubQ
FrequencyTwice daily (AM fasted + pre-bed)
Cycle8–12 weeks
Half-life~30 minutes
Follistatin 344
FS-344
Dose100 mcg daily (SubQ)
RouteSubQ
FrequencyOnce daily for 10–30 days
Cycle10–30 day cycles
Half-lifeUnknown (limited pharmacokinetic data)
Follistatin 315
FS-315
Dose100 mcg daily SubQ
RouteSubQ
FrequencyOnce daily
Cycle10–30 day cycles
Half-lifeShorter than FS-344 (tissue-bound)
ACE-031
Activin Receptor Type IIB Decoy
Dose1–3 mg/kg every 2 weeks (IV/SubQ)
RouteSubQ
FrequencyEvery 2 weeks
Cycle12–24 weeks in clinical trials
Half-life~10–15 days
Mechano Growth Factor (MGF)
MGF
Dose200 mcg per injection, site-specific (bilateral)
RouteIM
FrequencyPost-workout, into trained muscles
Cycle4–6 week cycles
Half-life~5–7 minutes
PEG-MGF
PEGylated Mechano Growth Factor
Dose200 mcg 2–3x per week (SubQ)
RouteSubQ
Frequency2–3x weekly on rest days
Cycle4–6 week cycles
Half-lifeSeveral days (PEGylation extends half-life)
IGF-1 LR3
Long R3 IGF-1
Dose20–80 mcg/day (SubQ or IM)
RouteSubQ
FrequencyOnce daily, often post-workout
Cycle4–6 week cycles maximum
Half-life20–30 hours
Ipamorelin
IPA
Dose200–300 mcg SC, 2–3x daily
RouteSubQ
Frequency2–3x daily, typically AM fasting + bedtime
Cycle8–12 week cycles with 4-week breaks
Half-life~2 hours
Modified GRF (1-29)
Mod GRF 1-29
Dose100–200 mcg SC, combined with GHRP
RouteSubQ
Frequency2–3x daily
Cycle8–12 week cycles
Half-life~30 minutes
IGF-1 DES
Des(1-3) IGF-1
Dose20–50 mcg IM per site
RouteIM
FrequencyPre-workout, target muscle
Cycle4-week max cycles
Half-life20–30 minutes
Metabolic & Body Composition
20 compoundsSemaglutide
Ozempic
Dose0.25 mg start → titrate by 0.25 mg every 4 weeks to tolerance
RouteSubQ
FrequencyOnce weekly, consistent day and time
Cycle6–12+ months with periodic reassessment
Half-life~7 days
DHEA
Dehydroepiandrosterone
Dose25–50 mg (men), 5–25 mg (women)
RouteOral
FrequencyOnce daily, morning
CycleOngoing with lab monitoring
Half-life15–38 hours
Pregnenolone
Preg
Dose50–100 mg daily
RouteOral
FrequencyOnce daily (morning)
CycleOngoing with TRT
Half-life1–2 hours
AOD-9604
Advanced Obesity Drug
Dose300–600 mcg daily
RouteSubQ
FrequencyOnce daily, fasted morning
Cycle8–12 weeks
Half-life~30 minutes
NAD+
Nicotinamide Adenine Dinucleotide
Dose100–200 mg SubQ per session
RouteSubQ
Frequency2–3x per week (SubQ)
CycleOngoing with periodic assessment
Half-lifevaries by route
Retatrutide
LY3437943
DoseStart 1 mg, increase to 2 mg, 4 mg, 6 mg, 8 mg weekly. Increase every 4 weeks.
RouteSubQ
FrequencyOnce weekly — half-life is 6 days, weekly dosing is pharmacology, not a suggestion
CycleLong-term — minimum 24 weeks for meaningful recomposition
Half-life~6 days
Tirzepatide
Mounjaro
Dose2.5–15 mg weekly, titrated every 4 weeks
RouteSubQ
FrequencyOnce weekly
CycleLong-term treatment — weight regain common upon discontinuation
Half-life~5 days
Liraglutide
Saxenda
DoseStart 0.6 mg, titrate to 3.0 mg over 4–5 weeks
RouteSubQ
FrequencyOnce daily
CycleLong-term — weight regain expected upon discontinuation
Half-life~13 hours
5-Amino-1MQ
5-Amino-1-Methylquinolinium
DosePreclinical: 10–20 mg/kg in mice; human equivalent ~50–100 mg/day
RouteOral
FrequencyOnce or twice daily
Cycle10+ days in animal models showed significant effects
Half-life~11–12 hours
Tesofensine
NS2330
Dose0.25 mg/day, increase to 0.5 mg if tolerated
RouteOral
FrequencyOnce daily
Cycle24+ weeks for full efficacy
Half-life~220 hours (~9 days)
AICAR
Acadesine
Dose150–500 mg/day SC
RouteSubQ
FrequencyOnce daily
Cycle4–8 week cycles
Half-life~2–3 hours
CagriSema
Cagrilintide + Semaglutide
DoseSlow titration to 2.4 mg/2.4 mg weekly
RouteSubQ
FrequencyOnce weekly
CycleLong-term chronic therapy
Half-life~5–7 days (combined)
Dulaglutide
Trulicity
Dose0.75–4.5 mg weekly
RouteSubQ
FrequencyOnce weekly
CycleLong-term
Half-life~5 days
Exenatide
Byetta
Dose5–10 mcg BID or 2 mg weekly
RouteSubQ
FrequencyTwice daily or once weekly
CycleLong-term
Half-life2.4 hours (Byetta); ~2 weeks (Bydureon extended-release)
Metformin
Glucophage
Dose500–1500 mg daily (longevity dosing)
RouteOral
FrequencyOnce daily at dinner or divided AM/PM
CycleOngoing with annual monitoring
Half-life4–8.7 hours
NMN (Nicotinamide Mononucleotide)
Nicotinamide Mononucleotide
Dose500–1000 mg daily
RouteOral
FrequencyOnce daily in the morning
CycleOngoing daily supplementation
Half-life~2–3 hours (oral NMN; NAD+ elevation lasts longer)
Resveratrol
Trans-Resveratrol
Dose500–1000 mg daily with fat
RouteOral
FrequencyOnce daily with breakfast
CycleOngoing
Half-life1–3 hours (but metabolites persist longer)
Berberine
Berberine HCl
Dose500–1500 mg daily, divided with meals
RouteOral
Frequency2–3x daily with meals
Cycle3–6 months then reassess
Half-life~3–4 hours
Creatine Monohydrate
Creatine
Dose3–5 g daily
RouteOral
FrequencyOnce daily, any time
CycleIndefinite — no cycling needed
Half-life~3 hours (plasma); tissue stores persist days
HGH Fragment 176-191
Fragment 176-191
Dose250–500 mcg SC, 1–2x daily
RouteSubQ
Frequency1–2x daily, fasted state
Cycle8–12 week cycles
Half-life~30 minutes
Longevity & Mitochondrial
4 compoundsGHK-Cu
Copper Peptide
DoseInjectable: 100–250 mcg/day (maintenance) to 2 mg/day (aggressive healing)
RouteSubQ
FrequencyDaily subcutaneous; topical 1–2x daily
Cycle12+ weeks for systemic effect
Half-life~30 min (injectable)
Epithalon
Epitalon
Dose5–10 mg/day during course
RouteSubQ
FrequencyOnce daily (10-day courses)
Cycle10-day courses, 2x per year
Half-life~hours
MOTS-c
Mitochondrial Open Reading Frame Peptide
Dose5–15 mg/week
RouteSubQ
Frequency2–3x per week
Cycle4–12 weeks
Half-life~30 minutes
Humanin
HN
Dose1–5 mg/day subcutaneous
RouteSubQ
FrequencyDaily
Cycle4–8 week cycles with 4-week breaks
Half-life~2–4 hours
Cognitive & Nootropic
1 compoundOxytocin
Pitocin
Dose20–40 IU intranasal
RouteNasal
FrequencyOnce daily or situationally
Cycle4–8 weeks or as-needed
Half-life3–5 minutes (IV); longer intranasal (central effects)
Immune Modulation
9 compoundsThymosin Alpha-1
Tα1
Dose1.6 mg 2x/week
RouteSubQ
FrequencyTwice weekly
CycleOngoing or seasonal (12–24 weeks)
Half-life~2 hours
LL-37
Cathelicidin
Dose50–100 mcg daily
RouteSubQ
FrequencyOnce daily
Cycle4–8 weeks per course
Half-life~4 hours
KPV
Lysine-Proline-Valine
Dose200–500 mcg daily
RouteOral
FrequencyOnce daily (oral, empty stomach)
Cycle4–8 weeks
Half-life~30 minutes
Thymalin
Thymic Factor
Dose10 mg/day IM for 10 days
RouteIM
FrequencyOnce daily during treatment course
Cycle10-day courses, 1–2 times per year
Half-life~30 minutes (rapid tissue distribution; immunomodulatory effects last days)
Thymulin
Facteur Thymique Serique
Dose50–100 mcg/day SC
RouteSubQ
FrequencyOnce daily for 2–4 week courses
Cycle2–4 weeks, repeated every 3–6 months
Half-life~2 hours
Glutathione
GSH
Dose500 mg liposomal oral daily; 1000–2000 mg IV weekly
RouteOral
FrequencyDaily oral; weekly or biweekly IV
CycleOngoing
Half-life~1.5–3 hours (oral); minutes IV (rapidly distributed to tissues)
Lactoferrin
Lactotransferrin
Dose300–600 mg/day oral on empty stomach
RouteOral
FrequencyOnce or twice daily, away from meals
CycleOngoing for immune support; 4–8 weeks for acute protocols
Half-life~4–6 hours (oral; longer tissue retention)
Beta-Glucans
β-Glucans
Dose250–500 mg/day yeast beta-glucan
RouteOral
FrequencyOnce daily on empty stomach
CycleOngoing — particularly through cold/flu season
Half-life~24 hours (immunomodulatory effects persist 24–48 hours after oral dosing)
Rapamycin (Sirolimus)
Sirolimus
Dose3–6 mg once weekly
RouteOral
FrequencyOnce weekly, same day each week
CycleOngoing with quarterly monitoring
Half-life57–63 hours
Sleep & Circadian
2 compoundsDSIP
Delta Sleep-Inducing Peptide
Dose100–300 mcg per dose
RouteSubQ
FrequencyOnce nightly (30 min before bed)
Cycle2–4 week courses
Half-life~15 minutes
Epifamin
Pineal gland bioregulator
Dose10 mg 2–3x/day
RouteOral
Frequency2–3 times daily during treatment course
Cycle10–15 day courses, 2–4 times per year
Half-life~3–4 hours (peptide fractions; pineal effects last 12–24 hours)
Sexual Health & Libido
11 compoundsPT-141
Bremelanotide
Dose0.5–2 mg, titrate to effective dose
RouteSubQ
FrequencyAs needed (max once daily)
CyclePer-use
Half-life~2.7 hours
Testosterone Cypionate
Test Cyp
Dose120–180 mg/week (split into 2 doses)
RouteIM
Frequency2x per week (e.g., Monday/Thursday)
CycleOngoing — lifetime protocol
Half-life8–12 days
Testosterone Enanthate
Test E
Dose100–200 mg/week (split doses)
RouteIM
Frequency2x per week
CycleOngoing — lifetime protocol
Half-life5–8 days
Testosterone Propionate
Test Prop
Dose20–50 mg EOD or 10–25 mg daily
RouteIM
FrequencyEvery other day or daily
CycleShort-term titration or ongoing
Half-life2–3 days
HCG
Human Chorionic Gonadotropin
Dose250 IU EOD or 500 IU 2x/week
RouteSubQ
FrequencyEvery other day or 2–3x per week
CycleContinuous with TRT
Half-life24–36 hours
Anastrozole
Arimidex
Dose0.125–0.5 mg per dose
RouteOral
Frequency1–3x per week (symptom-guided)
CycleAs needed — minimize chronic use
Half-life46–50 hours
Enclomiphene
Androxal
Dose12.5 mg EOD to 25 mg daily
RouteOral
FrequencyDaily or every other day
CycleOngoing with quarterly labs
Half-life10 hours
Melanotan II
MT-2
Dose0.25–0.5 mg per dose
RouteSubQ
FrequencyDaily loading → 1–2x/week maintenance
CycleLoading 7–10 days, then seasonal use
Half-life~1 hour
Kisspeptin-10
KP-10
Dose5–15 mcg/kg per dose
RouteSubQ
FrequencyVaries by research protocol
CycleAcute diagnostic or short-term therapeutic
Half-life~28 minutes
Gonadorelin
GnRH
Dose100–200 mcg 2–3x weekly
RouteSubQ
Frequency2–3x weekly SubQ
CycleOngoing alongside TRT
Half-life2–4 minutes
Triptorelin
Trelstar
Dose100 mcg single dose
RouteIM
FrequencyOnce only (not to be repeated)
CycleSingle injection, monitor recovery for 6–8 weeks
Half-life~3 hours (but depot formulations last weeks)
Neuroprotective
11 compoundsSelank
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Dose300–500 mcg per dose intranasally
RouteNasal
Frequency2–3x daily
Cycle2-week courses with breaks
Half-life~1–2 hours (intranasal)
Semax
ACTH 4-10 Analog
Dose200–600 mcg daily intranasal
RouteNasal
Frequency2–3 doses throughout the day
Cycle10–14 day courses, 2-week break between
Half-life~30 seconds (converted rapidly)
Dihexa
N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide
Dose10–40 mg daily (oral)
RouteOral
FrequencyOnce daily
Cycle2–4 weeks maximum (experimental)
Half-life~hours
SS-31 (Elamipretide)
Elamipretide
Dose40 mg daily subcutaneous
RouteSubQ
FrequencyOnce daily
Cycle12–24 weeks in clinical trials
Half-life~3–4 hours
Methylene Blue
MB
Dose0.5–1 mg oral, cycled (must not take continuously)
RouteOral
FrequencyOnce daily during on-cycle
Cycle4-week on / 2-week off cycles
Half-life5–6.5 hours
Cerebrolysin
FPE 1070
Dose5–10 mL IM daily for cognitive; 20–30 mL IV for acute neuro
RouteIM
FrequencyDaily for 10–20 day courses
Cycle10–20 day courses, 2–4 times per year
Half-life~1 hour (peptide fractions; neurotrophic effects persist days)
Cortexin
Cortex peptide complex
Dose10 mg/day IM reconstituted in 1–2 mL water for injection
RouteIM
FrequencyOnce daily during treatment course
Cycle10-day courses, 2–4 times per year
Half-life~1–2 hours (peptide fractions; neurotrophic effects last 24+ hours)
NA-Selank Amidate
N-Acetyl Selank Amidate
Dose300–600 mcg/day intranasal (100–200 mcg per spray)
RouteNasal
Frequency2–3 times daily
Cycle2–4 weeks on, 1–2 weeks off
Half-life~3–5 hours (significantly longer than standard Selank ~1–3 min)
P21
P021
DosePreclinical: 60 nmol/g in mice; human equivalent ~500–1000 mcg/day
RouteNasal
FrequencyOnce daily intranasal
Cycle30+ days in animal studies
Half-life~2–4 hours
FGL (FG Loop)
FGL peptide
DosePreclinical: 5–10 mg/kg in rodents; human equivalent ~1–5 mg
RouteSubQ
Frequency2–3 times weekly
Cycle4–8 weeks in animal studies
Half-life~4–6 hours
Noopept
GVS-111
Dose10–30 mg/day oral or sublingual
RouteOral
Frequency2–3 times daily, 10 mg per dose
Cycle6–8 week cycles with 2–4 week breaks
Half-life~5–10 minutes (parent compound; active metabolite cyclo-prolylglycine persists hours)
Anti-Aging & Skin
7 compoundsCollagen Peptides
Hydrolyzed Collagen
Dose10–15 g/day oral
RouteOral
FrequencyOnce daily, preferably on empty stomach with vitamin C
CycleOngoing supplementation (minimum 8 weeks for visible results)
Half-life~4 hours (dipeptides Pro-Hyp and Hyp-Gly in blood)
Copper Peptide AHK-Cu
AHK-Cu
DoseTopical application, 50–100 ppm
RouteTopical
FrequencyOnce or twice daily (topical)
Cycle3–6 months minimum for visible results
Half-lifeN/A (topical application)
Matrixyl (Palmitoyl Pentapeptide-4)
Palmitoyl Pentapeptide-4
Dose2–8% in topical formulation
RouteTopical
FrequencyTwice daily
CycleOngoing — cumulative benefits over months
Half-lifeN/A (topical depot in skin layers)
Argireline (Acetyl Hexapeptide-3)
Acetyl Hexapeptide-3
Dose5–10% topical, focused on dynamic wrinkle areas
RouteTopical
FrequencyTwice daily
CycleOngoing — effects reverse upon discontinuation
Half-lifeN/A (topical application)
SNAP-8 (Acetyl Octapeptide-3)
Acetyl Octapeptide-3
Dose3–10% topical solution
RouteTopical
FrequencyTwice daily
Cycle4–8 weeks for initial results
Half-lifeN/A (topical application)
Leuphasyl (Pentapeptide-18)
Pentapeptide-18
Dose3–8% topical solution
RouteTopical
FrequencyTwice daily, combined with Argireline
Cycle4–8 weeks for initial results
Half-lifeN/A (topical application)
Palmitoyl Tetrapeptide-7
Pal-GQPR
DoseAs part of Matrixyl 3000 complex, 2–5%
RouteTopical
Frequency2x daily
CycleOngoing
Half-lifeN/A (topical — local effect in skin)